| |
 |
Novartis AG Patents |
|
Assignee: Novartis AG
Address: Basel, CH
No. of patents: 924
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| RE40596 |
Rapamycin assay |
December 2, 2008 |
| Monoclonal antibodies to rapamycin and to 40-O-alkylated derivatives of rapamycin are provided, together with novel haptens, immunogenic conjugates, and processes for making them and assay kits for using them. |
| PP11231 |
Verbena plant named `Morena` |
February 22, 2000 |
| A new and distinct variety of Verbena plant, named Morena, characterized particularly as to novelty by large, early-appearing, vivid pink flowers, and a growth habit that is initially semi-erect but later spreading and hanging. |
| PP11197 |
Verbena plant named `Silvena` |
February 1, 2000 |
| A new and distinct variety of Verbena plant, named Silvena, characterized particularly as to novelty by large, early-appearing purple flowers, and a growth habit that is initially semi-erect but later spreading and hanging. |
| PP11192 |
Verbena plant named `Mylena` |
January 25, 2000 |
| A new and distinct variety of Verbena plant, named Mylena, characterized particularly as to novelty by large, early appearing, dark purple flowers, and a growth habit that is initially semi-erect but later spreading and hanging. |
| H1973 |
Human neutrophil collagenase splice variant |
July 3, 2001 |
| The subject invention is related to human MMP-8alt genes and gene products and their differential expression when comparing a patient with a disease state to a control. A further aspect of the invention concerns compounds which antagonize the biological activity of MMP-8alt protein and m |
| D604502 |
Combined pill container and lid |
November 24, 2009 |
|
| D591418 |
Nebulizer |
April 28, 2009 |
|
| D579550 |
Inhaler |
October 28, 2008 |
|
| D579549 |
Inhaler |
October 28, 2008 |
|
| D579548 |
Inhaler |
October 28, 2008 |
|
| D579547 |
Inhaler |
October 28, 2008 |
|
| D579546 |
Inhaler |
October 28, 2008 |
|
| D579545 |
Inhaler |
October 28, 2008 |
|
| D579544 |
Inhaler |
October 28, 2008 |
|
| D574230 |
Package for an ophthalmic product |
August 5, 2008 |
|
| D573836 |
Spill resistant lid |
July 29, 2008 |
|
| D553733 |
Tablet |
October 23, 2007 |
|
| D548087 |
Bottle |
August 7, 2007 |
|
| D538661 |
Bottle |
March 20, 2007 |
|
| D530814 |
Combined capsule and tablets |
October 24, 2006 |
|
| D529821 |
Food tray |
October 10, 2006 |
|
| D529797 |
Food tray |
October 10, 2006 |
|
| D527817 |
Inhaler |
September 5, 2006 |
|
| D520635 |
Combine capsule and tablets |
May 9, 2006 |
|
| D474841 |
Dosage device |
May 20, 2003 |
|
| D420739 |
Injector |
February 15, 2000 |
|
| D420736 |
Attachment for an inhaler |
February 15, 2000 |
|
| D411801 |
Aerosol dispenser cap |
July 6, 1999 |
|
| D410541 |
Inhaler |
June 1, 1999 |
|
| 7622484 |
Mixtures or organic compounds for the treatment of airway diseases |
November 24, 2009 |
| A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, |
| 7622483 |
.beta.2-adrenoceptor agonists |
November 24, 2009 |
| Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification, |
| 7615635 |
N-formyl hydroxylamines |
November 10, 2009 |
| Novel N-formyl hydroxylamine compounds and their derivatives are disclosed. These N-formyl hydroxylamine compounds inhibit peptidyl deformylase (PDF), an enzyme present in prokaryotes. The compounds are useful as antimicrobials and antibiotics. The compounds of the invention display |
| 7615609 |
Preparation of somatostatin peptides |
November 10, 2009 |
| Provided is a process for preparing cyclic somatostatin analogues and the linear intermediates used in this process. |
| 7615562 |
2-aminopyrimidine derivatives and their medical use |
November 10, 2009 |
| A compound of formula I or a pharmaceutically acceptable salt, ester or prodrug thereof wherein the variables have the meanings as defined in the specification. Further disclosed are a method of inhibiting IKK activity using a compound of formula I, a method of inhibiting production of T |
| 7615523 |
Lens care product containing dexpanthenol |
November 10, 2009 |
| The present invention relates to contact lens care product comprising dexpanthenol. The invention similarly relates to the usage of a contact lens care compositions of this kind for cleaning and optionally disinfecting contact lenses. |
| 7612238 |
Amino-propanol derivatives |
November 3, 2009 |
| Compounds of formula I ##STR00001## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them. |
| 7612055 |
Macrocyclic lactams and pharmaceutical use thereof |
November 3, 2009 |
| The present invention relates to novel macrocyclic compounds of the formula ##STR00001## wherein R.sub.1, R.sub.2, R.sub.3, U, V, W, X, Y, Z and n are as defined in the specification, the number of ring atoms included in the macrocyclic ring being 14, 15, 16 or 17, in free base form |
| 7612054 |
Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
November 3, 2009 |
| The present invention pertains to novel dibenzo[b,f]oxepine-10-carboxamides compound to a process for the preparation of such compounds of formula I, their use as a pharmaceuticals, especially in the treatment of neurological and vascular disorders related to beta-amyloid generation |
| 7612052 |
Combinations comprising epothilones and pharmaceutical uses thereof |
November 3, 2009 |
| The invention relates to a combination which comprises (a) a bisphosphonate, a platinum compound or a vasculostatic compound and (b) an epothilone derivative of formula I ##STR00001## wherein A represents O or NR.sub.N, wherein R.sub.N is hydrogen or lower alkyl, R is hydrogen or lo |
| 7605267 |
Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones |
October 20, 2009 |
| The invention relates to a process for preparing 5-(.alpha.-haloacetyl)-8-substituted oxy-(1H)-quinolin-2-ones. The process involves (i) reacting (a) 8-hydroxy-(1H)-quinolin-2-one with an acylating agent and a Lewis acid to form 5-acetyl-8-hydroxy-(1H)-quinolin-2-one; or (b) 8-hy |
| 7595390 |
Industrially scalable nucleoside synthesis |
September 29, 2009 |
| An industrially scalable two-step process for preparing a .beta.-L-2'-deoxy-nucleoside that results in a predominance of the .beta.- over the .alpha.-anomeric form of the compound is described. An optional third step may be used to prepare 3'-prodrugs of desirable .beta.-L-2'-deoxy-n |
| 7592349 |
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptor |
September 22, 2009 |
| Described herein are compounds that include a diarylamine structural feature. Also described herein are methods for making such compounds, methods for using such compounds to modulate the activity of c-kit receptors, and pharmaceutical compositions and medicaments comprising such com |
| 7589216 |
Process for preparing N-hydroxyformamido-propyl pyrrolidin compounds and intermediates |
September 15, 2009 |
| The present invention is directed to a process for preparing intermediates that are useful to prepare certain antibacterial N-formyl hydroxylamine compounds which are peptide deformylase inhibitors. The process makes use .alpha. .beta.-lactarn intermediate. Certain optically pure interme |
| 7589091 |
Hydroxamic acid derivatives |
September 15, 2009 |
| Novel hydroxamic acid derivatives, e.g., of formula (I), wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are as defined, are found to be useful as pharmaceuticals, e.g., for the suppression of TNF release and the treatment of autoimmune and inflammatory diseases, e.g., multiple scleros |
| 7589079 |
Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
September 15, 2009 |
| Physical forms of beta-L-2'-deoxythymidine are disclosed that can be characterized by physical appearance, purity levels, Infra-Red and Raman spectroscopy, X-ray powder diffraction patterns, thermal properties, and methods of manufacture. These forms of beta-L-2'-deoxythymidine can be |
| 7582782 |
Organic compounds |
September 1, 2009 |
| Disclosed are .delta.-amino-.gamma.-hydroxy-.omega.-aryl-alkanoic acid amide compounds of formula (I) ##STR00001## and the salts thereof, having renin-inhibiting properties. Also disclosed are pharmaceutical compositions comprising these compounds and methods of administering them f |
| 7582327 |
LbL-coated medical device and method for making the same |
September 1, 2009 |
| The present invention provides a medical device, preferably an ophthalmic device, more preferably a contact lens, which comprises a core material and a biocompatible LbL coating non-covalently attached to said core material. The biocompatible LbL coating comprises at least one charge |
| 7579467 |
N-phenyl-2-pyrimidine-amine derivatives |
August 25, 2009 |
| The present invention relates to novel amides and a process for preparing these amides. |
| 7579362 |
Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists |
August 25, 2009 |
| The present invention relates to 1-aza-bicycloalkyl derivatives of formula I, ##STR00001## wherein X is CH.sub.2 or a single bond; Y is a group of formula ##STR00002## and wherein R has the meanings as defined in the specification, which compounds are alpha 7 nicotinic acetylcholine |
| 7573974 |
Device and method for non-contact scanning of contact lens and contact lens mold geometry |
August 11, 2009 |
| The invention relates to an apparatus and method for non-contact/non-destructive measurement of the geometry of molded ophthalmic lenses and the precision molds and tooling used in the manufacture of the ophthalmic lenses. In particular the present system uses micro computed tomograp |
|
|
|
